Cargando…
Improved glucose tolerance with DPPIV inhibition requires β‐cell SENP1 amplification of glucose‐stimulated insulin secretion
Pancreatic islet insulin secretion is amplified by both metabolic and receptor‐mediated signaling pathways. The incretin‐mimetic and DPPIV inhibitor anti‐diabetic drugs increase insulin secretion, but in humans this can be variable both in vitro and in vivo. We examined the correlation of GLP‐1 indu...
Autores principales: | Ferdaoussi, Mourad, Smith, Nancy, Lin, Haopeng, Bautista, Austin, Spigelman, Aliya F., Lyon, James, Dai, XiaoQing, Manning Fox, Jocelyn E., MacDonald, Patrick E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185381/ https://www.ncbi.nlm.nih.gov/pubmed/32339440 http://dx.doi.org/10.14814/phy2.14420 |
Ejemplares similares
-
β-Cell Knockout of SENP1 Reduces Responses to Incretins and Worsens Oral Glucose Tolerance in High-Fat Diet–Fed Mice
por: Lin, Haopeng, et al.
Publicado: (2021) -
PI3 kinases p110α and PI3K-C2β negatively regulate cAMP via PDE3/8 to control insulin secretion in mouse and human islets
por: Kolic, Jelena, et al.
Publicado: (2016) -
Impacts of the COVID-19 pandemic on a human research islet program
por: Dafoe, Tina J., et al.
Publicado: (2022) -
A role for PKD1 in insulin secretion downstream of P2Y(1) receptor activation in mouse and human islets
por: Khan, Shara, et al.
Publicado: (2019) -
SUMOylation and calcium control syntaxin-1A and secretagogin sequestration by tomosyn to regulate insulin exocytosis in human ß cells
por: Ferdaoussi, Mourad, et al.
Publicado: (2017)